Align Technology [ALGN] vs West Pharmaceutical [WST] Detailed Stock Comparison

Align Technology Inc.

NASDAQ
Loading...

West Pharmaceutical Services Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Align Technology Inc. wins in 11 metrics, West Pharmaceutical Services Inc. wins in 9 metrics, with 0 ties. Align Technology Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Align Technology Inc. West Pharmaceutical Services Inc. Better
P/E Ratio (TTM) 34.70 40.99 Align Technology Inc.
Price-to-Book Ratio 3.46 6.94 Align Technology Inc.
Debt-to-Equity Ratio 2.83 10.73 Align Technology Inc.
PEG Ratio 0.96 0.74 West Pharmaceutical Services Inc.
EV/EBITDA 15.26 24.63 Align Technology Inc.
Profit Margin (TTM) 10.17% 16.85% West Pharmaceutical Services Inc.
Operating Margin (TTM) 22.38% 21.70% Align Technology Inc.
EBITDA Margin (TTM) 22.38% 21.70% Align Technology Inc.
Return on Equity 10.39% 19.13% West Pharmaceutical Services Inc.
Return on Assets (TTM) 6.94% 11.21% West Pharmaceutical Services Inc.
Free Cash Flow (TTM) $490.78M $468.90M Align Technology Inc.
Dividend Yield N/A 0.46% N/A
1-Year Return -3.31% 53.10% West Pharmaceutical Services Inc.
Price-to-Sales Ratio (TTM) 3.48 6.72 Align Technology Inc.
Enterprise Value $12.99B $21.43B West Pharmaceutical Services Inc.
EV/Revenue Ratio 3.22 6.65 Align Technology Inc.
Gross Profit Margin (TTM) 65.26% 35.08% Align Technology Inc.
Revenue per Share (TTM) $56 $45 Align Technology Inc.
Earnings per Share (Diluted) $5.65 $7.47 West Pharmaceutical Services Inc.
Beta (Stock Volatility) 1.81 1.15 West Pharmaceutical Services Inc.
Short % of Float 6.94% 4.38% West Pharmaceutical Services Inc.

Align Technology Inc. vs West Pharmaceutical Services Inc. Stock Performance Analysis

Loading Price Chart...

ALGN
WST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Align Technology Inc.-2.99%1.92%-3.02%-11.81%10.44%6.83%
West Pharmaceutical Services Inc.1.33%-1.27%3.99%24.25%14.34%12.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Align Technology Inc.-3.31%-42.07%-69.96%123.15%641.63%2,145.83%
West Pharmaceutical Services Inc.53.10%-6.09%-3.19%328.98%1,367.32%1,736.23%

Performance & Financial Health Analysis: Align Technology Inc. vs West Pharmaceutical Services Inc.

MetricALGNWST
Market Information
Market Cap i$13.66B$22.07B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i986,3841,085,830
90 Day Avg. Volume i1,182,935930,327
Last Close$161.71$316.31
52 Week Range$122.00 - $208.31$206.19 - $330.88
% from 52W High-22.37%-4.40%
All-Time High$737.45 (Sep 20, 2021)$475.35 (Sep 06, 2021)
% from All-Time High-78.07%-33.46%
Growth Metrics
Quarterly Revenue Growth0.05%0.21%
Quarterly Earnings Growth0.31%0.55%
Financial Health
Profit Margin (TTM) i0.10%0.17%
Operating Margin (TTM) i0.22%0.22%
Return on Equity (TTM) i0.10%0.19%
Debt to Equity (MRQ) i2.8310.73
Cash & Liquidity
Book Value per Share (MRQ)$56.74$44.11
Cash per Share (MRQ)$15.36$7.38
Operating Cash Flow (TTM) i$593.22M$715.30M
Levered Free Cash Flow (TTM) i$483.69M$275.66M
Dividends
Last 12-Month Dividend Yield iN/A0.46%
Last 12-Month Dividend iN/A$1.07

Valuation & Enterprise Metrics Analysis: Align Technology Inc. vs West Pharmaceutical Services Inc.

MetricALGN (Apr 24, 2026)WST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i34.7040.99
Forward P/E i15.9232.05
PEG Ratio i0.960.74
Price to Sales (TTM) i3.486.72
Price to Book (MRQ) i3.466.94
Market Capitalization
Market Capitalization i$13.66B$22.07B
Enterprise Value i$12.99B$21.43B
Enterprise Value Metrics
Enterprise to Revenue i3.226.65
Enterprise to EBITDA i15.2624.63
Risk & Other Metrics
Beta i1.811.15
Book Value per Share (MRQ) i$56.74$44.11

Financial Statements Comparison: Align Technology Inc. vs West Pharmaceutical Services Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricALGN (2025)WST (2025)
Revenue/Sales i4.03B3.07B
Cost of Goods Sold i1.32B1.97B
COGS % of Revenue i32.8%64.1%
Gross Profit i2.71B1.10B
Gross Margin i67.2%35.9%
Research & Development i369.91M74.30M
Operating Income (EBIT) i585.31M636.10M
Operating Margin i14.5%20.7%
EBITDA i862.30M822.70M
EBITDA Margin i21.4%26.8%
Pre-Tax Income i585.29M600.90M
Pre-Tax Income % of Revenue i14.5%19.5%
Income Tax i174.94M121.60M
Income Tax % of Revenue i4.3%4.0%
Net Income (Profit) i410.35M493.70M
Profit Margin i10.2%16.1%

Balance Sheet & Liquidity Metrics

MetricALGN (2025)WST (2025)
Cash & Equivalents i1.09B791.30M
Total Current Assets i2.62B1.98B
Total Current Assets % of Revenue i64.8%64.4%
Total Current Liabilities i1.92B654.90M
Total Current Liabilities % of Revenue i47.6%21.3%
Long-Term Debt i82.51M298.40M
Long-Term Debt % of Revenue i2.0%9.7%
Total Shareholders Equity i4.05B3.18B
Retained Earnings i2.46B4.37B
Retained Earnings % of Revenue i61.1%142.3%
Property, Plant & Equipment i956.80M296.40M

Cash Flow Statement Comparison

MetricALGN (2025)WST (2025)
Operating Cash Flow i698.64M753.00M
Operating Cash Flow % of Revenue i17.3%24.5%
Capital Expenditures i-102.45MN/A
Free Cash Flow i490.78M468.90M
FCF Margin i12.2%15.3%
Debt Repayment iN/A-1.10M
Common Stock Repurchase i-465.94M-136.80M

Short Interest & Institutional Ownership Analysis

MetricALGNWST
Shares Short i4.35M2.66M
Short Ratio i3.343.18
Short % of Float i6.94%4.38%
Shares Outstanding i71.36M70.90M
Float Shares i66.73M70.15M
% Held by Insiders i6.82%0.64%
% Held by Institutions i97.35%99.21%
% Held by Public i-4.17%0.15%

Dividend Analysis & Yield Comparison: Align Technology Inc. vs West Pharmaceutical Services Inc.

MetricALGNWST
Last 12-Month Dividend iN/A$1.07
Last 12-Month Dividend Yield iN/A0.46%
3-Year Avg Annual Dividend iN/A$0.82
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$2.46
Ex-Dividend DateN/AJan 28, 2026